| scholarly article | Q13442814 |
| P50 | author | Markus Riester | Q41050073 |
| Massimo Squatrito | Q55459211 | ||
| Eric C Holland | Q89747805 | ||
| Franziska Michor | Q33177805 | ||
| P2093 | author name string | Jason T Huse | |
| Tatsuya Ozawa | |||
| Nikki Charles | |||
| Karim Helmy | |||
| Yu-Kang Cheng | |||
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| Mechanism of action and in vivo role of platelet-derived growth factor | Q22010594 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma | Q24612429 | ||
| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| The neighbor-joining method: a new method for reconstructing phylogenetic trees | Q25939010 | ||
| Genetic instabilities in human cancers | Q28131826 | ||
| Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects | Q28511432 | ||
| lumi: a pipeline for processing Illumina microarray | Q29614924 | ||
| Role of platelet-derived growth factors in physiology and medicine | Q29615222 | ||
| Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model | Q38335045 | ||
| Visualization of interphase chromosomes in postmitotic cells of the human brain by multicolour banding (MCB). | Q38468748 | ||
| mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma | Q40407116 | ||
| Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice | Q40881142 | ||
| Modeling Adult Gliomas Using RCAS/t-va Technology | Q41843698 | ||
| Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma | Q42013793 | ||
| Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis | Q42827324 | ||
| Aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: differential expression and pathological meaning | Q43598274 | ||
| Generation of RCAS vectors useful for functional genomic analyses. | Q43826373 | ||
| PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling | Q46365844 | ||
| PTEN methylation and expression in glioblastomas | Q48232099 | ||
| Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. | Q52008070 | ||
| Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
| Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations | Q30885944 | ||
| Aneuploidy and confined chromosomal mosaicism in the developing human brain. | Q33288955 | ||
| The transcriptional network for mesenchymal transformation of brain tumours. | Q33572162 | ||
| A differentiation-based phylogeny of cancer subtypes | Q33576721 | ||
| Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation | Q33656940 | ||
| p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation | Q33733341 | ||
| Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells. | Q33872283 | ||
| Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression | Q33960280 | ||
| A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis | Q34126248 | ||
| PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas | Q34164924 | ||
| A mathematical framework to determine the temporal sequence of somatic genetic events in cancer | Q34200279 | ||
| Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma | Q34509145 | ||
| Chronic myeloid leukaemia | Q34657509 | ||
| PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo | Q35080265 | ||
| Mosaic analysis with double markers reveals tumor cell of origin in glioma | Q35127020 | ||
| A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice | Q35211546 | ||
| Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice | Q35801259 | ||
| Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. | Q36269892 | ||
| Identification of global alteration of translational regulation in glioma in vivo | Q36295318 | ||
| PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo | Q36453531 | ||
| Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma | Q36528386 | ||
| Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Q36673354 | ||
| Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice | Q36677747 | ||
| The genomically mosaic brain: aneuploidy and more in neural diversity and disease | Q36799509 | ||
| Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis | Q37115208 | ||
| Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. | Q37279893 | ||
| Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas | Q37281335 | ||
| Pten haploinsufficiency accelerates formation of high-grade astrocytomas | Q37384874 | ||
| The definition of primary and secondary glioblastoma | Q38064831 | ||
| P433 | issue | 2 | |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 288-300 | |
| P577 | publication date | 2014-08-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma | |
| P478 | volume | 26 |
| Q89291590 | A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB |
| Q58799676 | A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine |
| Q44457966 | A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics |
| Q96348394 | A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways |
| Q88701275 | A new method of identifying glioblastoma subtypes and creation of corresponding animal models |
| Q89724165 | A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level |
| Q33761660 | A peptide derived from apoptin inhibits glioma growth |
| Q98154728 | A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures |
| Q37269034 | ABCG1 maintains high-grade glioma survival in vitro and in vivo. |
| Q64068988 | ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis |
| Q48446221 | ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma |
| Q57296293 | Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival |
| Q38364234 | Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future? |
| Q40974703 | Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma |
| Q55456769 | Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors. |
| Q38858314 | Applications of the CRISPR/Cas9 system in murine cancer modeling |
| Q66679168 | Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma |
| Q38839352 | Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma |
| Q90058737 | Astrocytes enhance glioblastoma growth |
| Q47304287 | Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastomas |
| Q48228839 | Brain Tumor Stem Cells Remain in Play |
| Q97542930 | Brain tumors in Neurofibromatosis type 1 |
| Q55351090 | CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma. |
| Q55010335 | CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells. |
| Q26781783 | Cancer classification in the genomic era: five contemporary problems |
| Q93260327 | Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis |
| Q35128022 | Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma |
| Q63151952 | Chronic platelet-derived growth factor receptor signaling exerts control over initiation of protein translation in glioma |
| Q90365564 | Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme |
| Q59333163 | Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics |
| Q35573268 | Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme. |
| Q34513800 | Collateral Lethality: A new therapeutic strategy in oncology |
| Q33777905 | Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas |
| Q33786677 | Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity. |
| Q37649442 | Cooperative genomic alteration network reveals molecular classification across 12 major cancer types |
| Q47851037 | Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma. |
| Q42366669 | Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries? |
| Q30276928 | Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells |
| Q38677899 | Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence |
| Q54153689 | Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression. |
| Q55456904 | Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma. |
| Q61794394 | Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma |
| Q42228181 | Double minute amplification of mutant PDGF receptor α in a mouse glioma model |
| Q37269061 | Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. |
| Q48014727 | EGFR heterogeneity and implications for therapeutic intervention in glioblastoma |
| Q55080493 | ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells. |
| Q90429073 | Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma |
| Q47154528 | Engineering PTEN-L for Cell-Mediated Delivery. |
| Q42529862 | EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells |
| Q50100856 | Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. |
| Q46890724 | Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression. |
| Q37217995 | Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model |
| Q64230366 | Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes |
| Q64880162 | Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas. |
| Q30275293 | Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis |
| Q47970311 | Frozen tissue preparation for high-resolution multiplex histological analyses of human brain specimens |
| Q47912595 | Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas. |
| Q97433113 | Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade |
| Q36328555 | Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. |
| Q26823823 | Glioblastoma Circulating Cells: Reality, Trap or Illusion? |
| Q64056689 | Glioblastoma Stem- Cells, Metabolic Strategy to Kill a Challenging Target |
| Q47097367 | Glioblastoma and glioblastoma stem cells are dependent on functional MTH1. |
| Q38460865 | Glioblastoma: pathology, molecular mechanisms and markers |
| Q100454881 | Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression |
| Q46820292 | Glioma. |
| Q38366332 | Glycosylation alterations in lung and brain cancer |
| Q41824050 | HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss |
| Q45870735 | Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas |
| Q27013006 | Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma |
| Q33646231 | High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients. |
| Q36379857 | Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis |
| Q92353570 | IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma |
| Q97543429 | Identification of functionally distinct and interacting cancer cell subpopulations from glioblastoma with intratumoral genetic heterogeneity |
| Q47915209 | Immunotherapies for malignant glioma. |
| Q92013024 | Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma |
| Q38618205 | Implications of mitogen-activated protein kinase signaling in glioma. |
| Q36299611 | In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma |
| Q52597914 | Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma. |
| Q42101562 | Induction of senescence in primary glioblastoma cells by serum and TGFβ. |
| Q38737715 | Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma. |
| Q47756210 | Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis |
| Q92666770 | LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy |
| Q58730941 | Lgl1 controls NG2 endocytic pathway to regulate oligodendrocyte differentiation and asymmetric cell division and gliomagenesis |
| Q41101267 | Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells. |
| Q93012197 | Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells |
| Q36232178 | Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma |
| Q49390262 | Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma |
| Q33744534 | Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies |
| Q57116103 | Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway |
| Q49639816 | MethCNA: a database for integrating genomic and epigenomic data in human cancer |
| Q58121730 | Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity |
| Q91966182 | Modeling Gliomas Using Two Recombinases |
| Q38453759 | Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma |
| Q48010499 | Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification |
| Q47738114 | Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data |
| Q97072841 | Multimodal single-cell analysis reveals distinct radioresistant stem-like and progenitor cell populations in murine glioma |
| Q97653033 | Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution |
| Q55457207 | Mutant IDH1 Promotes Glioma Formation In Vivo. |
| Q42259199 | Mutant IDH1 regulates the tumor-associated immune system in gliomas |
| Q58779206 | NF-κB, Mesenchymal Differentiation and Glioblastoma |
| Q48018806 | Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma. |
| Q58576103 | Next-Generation Modeling of Human Cancers |
| Q37301799 | Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma |
| Q37097023 | Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma |
| Q55456695 | Oligosaccharyltransferase inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity. |
| Q45916518 | Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells. |
| Q64975191 | Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma. |
| Q47109987 | PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT. |
| Q55457210 | PI3K Activation in Neural Stem Cells Drives Tumorigenesis which can be Ameliorated by Targeting the cAMP Response Element Binding (CREB) Protein. |
| Q37702754 | PREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion |
| Q92987374 | Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness |
| Q37240846 | Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial |
| Q36803476 | Pediatric gliomas as neurodevelopmental disorders |
| Q64946837 | Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. |
| Q38262433 | Platelet-derived growth factor in glioblastoma-driver or biomarker? |
| Q39223541 | Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells. |
| Q36200482 | Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes |
| Q41718329 | Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models |
| Q50026526 | Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages. |
| Q90376867 | Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2 |
| Q35376154 | Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation. |
| Q47583690 | Prognostic relevance of genetic alterations in diffuse lower-grade gliomas |
| Q92544093 | Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma |
| Q48167510 | Putting Glioblastoma in Its Place: IRF3 Inhibits Invasion |
| Q38732473 | Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture |
| Q92089518 | Quantitative proteomics reveals reduction of endocytic machinery components in gliomas |
| Q35306157 | Radiological and pathological features associated with IDH1-R132H mutation status and early mortality in newly diagnosed anaplastic astrocytic tumours |
| Q52608306 | Reconstructing the molecular life history of gliomas. |
| Q52668450 | Revisit the Candidacy of Brain Cell Types as the Cell(s) of Origin for Human High-Grade Glioma. |
| Q47829797 | Significance of perivascular tumour cells defined by CD109 expression in progression of glioma. |
| Q42572216 | Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation |
| Q38927317 | Spatiotemporal genomic architecture informs precision oncology in glioblastoma |
| Q52724352 | Spontaneous development of intratumoral heterogeneity in a transposon-induced mouse model of glioma. |
| Q43494911 | Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. |
| Q92702657 | The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas |
| Q89686775 | The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically |
| Q89587165 | The Sociobiology of Brain Tumors |
| Q48532756 | The angiogenic switch leads to a metabolic shift in human glioblastoma |
| Q39132571 | The evolution of tumour phylogenetics: principles and practice |
| Q64101370 | The landscape of the mesenchymal signature in brain tumours |
| Q90412264 | The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1 |
| Q33744491 | The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas |
| Q46410671 | Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. |
| Q47104172 | Ubiquitin Specific Peptidase 15 (USP15) suppresses glioblastoma cell growth via stabilization of HECTD1 E3 ligase attenuating WNT pathway activity. |
| Q57040018 | Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma |
| Q36250650 | pH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in Glioblastoma |
Search more.